About Us
Why Alkemi
Alkemi establishes patient access in a rapidly evolving, evidence-based, and value-conscious health policy environment. Our projects deliver strategic and tactical plans and often include design and execution of evidence studies, development and training on communication tools and participation or leadership of negotiations with regulator, payer, and institutional decision-makers to enable patient access.
Our Expertise
Decades of senior-level industry experience in medical and commercial roles
Experience negotiating novel payment and access arrangements across markets
Practical application of market access and evidence strategies
Our Values
Advance Health Outcomes
We effectively pursue the strategic goals of our clients toward achieving better health outcomes. We provide excellence in life sciences consulting to healthcare stakeholders to improve the quality of care and patient, provider, and payer outcomes.
Integrity
We do what is right for our clients, our employees, and the global healthcare community. In the pursuit of client goals, we relentlessly seek solutions that advance meaningful outcomes for providers, payers, public policy, and patient stakeholders through evidence-based research.
Deliver Value
At all times, we pursue the strategic goals of our clients toward achieving better health outcomes.
Meet our Team
Betsy J. Lahue, MPH
CEO
Robert H. Lahue
COO
Kristen Cribbs, PhD, MPH
Senior Research Director
Wesley Baisley
Research Associate
Gio Shoushi, MS
Research Analyst
Lailoo Perriello
Research Analyst
Lucas Blackmore, MPH
HEOR Fellow
Like the compass rose, the Alkemi logo has eight points symbolizing the true North orientation and direction we provide to our clients as they navigate a competitive and complex payment and access landscape.
Our colors, Green and Gold, represent Value and Access.
Gold: Lasting and rare value that is recognized with compelling outcomes evidence.
Green: The idea of patients given the “green light” by payers, guideline groups and HTA decision-makers for access to medical innovation.
Our History
Alkemi formed to provide Evidence and Access Support to innovative medical partners
Engaged on five rare disease assets across two fortune 500 companies
Evidence Communications: Payer dossiers and medical training decks
Landscape Monitoring: Evidence insights
Evidence Design and Analytical Support: Data Analysis
HEOR Partner: Operational Support
Global Expert Network: HEOR and Market Access Analysis
Celebrating 5 years of excellence in Health Economics and Outcomes Research, and Market Access Consulting!
Recognized by Inc. Magazine 2023: Fastest-Growing Companies at #37 in the Northeast United States
Alkemi Ranks No. 395 on the Inc. 5000 - Among America's Fastest-Growing Private Companies
We are driven by our vision of advancing public health, delivering value in healthcare, and improving patient outcomes. Utilizing our healthcare experience and global payer expertise, we provide clients with strategic tools and resources required to bring medical innovation to patients. Our creativity and novel value demonstration approaches meet requirements for commercial enterprises, healthcare providers, and payers. In doing so, we ensure that patients have rapid access to the most effective and efficient treatments available.